Cetera Investment Advisers’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Buy
29,849
+8,419
+39% +$303K ﹤0.01% 2726
2026
Q1
$525K Buy
21,430
+2,863
+15% +$67.8K ﹤0.01% 3465
2025
Q4
$461K Buy
+18,567
New +$493K ﹤0.01% 3507

Other funds holding ASTH

Cetera Investment Advisers's ASTH Position: Q2 2026 in Review

Cetera Investment Advisers increased its Astrana Health (ASTH) stake by 39% in Q2 2026, buying an estimated $303K and bringing the position to 29,849 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

Cetera Investment Advisers first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Cetera Investment Advisers held 29,849 shares of Astrana Health worth $1.39M as of Q2 2026.
  • Cetera Investment Advisers bought 8,419 Astrana Health shares in Q2 2026, an estimated $303K.
  • Astrana Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2726 holding.
  • Cetera Investment Advisers first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.